ORIGINAL ARTICLE Systolic hypertensive response at exercise and cardiovascular events 855 suggested to be 5% to 40%. 2,3 However, there is no consensus on the exact definition or validated cutoff value for SHRE. In most publications, the SHRE is defined as a difference of 60 mm Hg between baseline and peak SBP for men and 50 mm Hg for women, or SBP at peak exercise exceeding the 90th percentile (>210 mm Hg for men and >190 mm Hg for women) or diastolic >110 mm Hg in either sex. 4-7 The respective values at moderate exercise (100 Watt) are an SBP KEY WORDS cardiovascular events, exercise -induced hypertension, stress test, systolic hypertensive response to exercise ABSTRACT INTRODUCTION The pathophysiology of exaggerated systolic hypertensive response to exercise (SHRE) is not fully understood, with contradictory data on its role in predicting cardiovascular (CV) events.
INTRODUCTION Exercise stress testing is mainly used for the assessment of coronary artery disease (CAD), with blood pressure (BP) measurements obtained as an integral part of the test. 1 In healthy individuals, an increased cardiac output with exercise is associated with a constant increase in systolic BP (SBP), but diastolic BP (DBP) remains unchanged or may slightly fall. The prevalence of exaggerated systolic hypertensive response to exercise (SHRE) has previously been
ORIGINAL ARTICLE
Exaggerated systolic hypertensive response to exercise predicts cardiovascular events: a systematic review and meta -analysis Criteria for study inclusion Studies were included in the meta -analysis if they met the following criteria: 1) published in a peer -reviewed, English -language journal; 2) a human study involving adults older than 18 years of age; 3) reporting office BP; 4) reporting exercise BP (measured during, at submaximal [moderate], and maximal workload); (5) reporting CV outcomes; and 6) including individuals with a clinical indication for exercise stress testing or who were otherwise healthy and normotensive. From this meta -analysis, we excluded studies that enrolled: 1) patients with a history of any CV disease; 2) patients with end -target organ damage (severe renal or liver disease); and 3) patients in whom exercise BP was only measured during recovery periods (not during exercise). We included only studies reporting categorical data, in which SHRE and non -SHRE were compared, while continuous data were not analyzed due to the heterogeneous way of reporting. No restrictions were applied to the duration of follow -up, including newly diagnosed type 2 diabetes. After individual analysis, the final studies included in this systematic review and meta -analysis were unanimously accepted by the 2 reviewers (LP and GB). The outcomes investigated in this meta -analysis were: 1) coronary events (acute coronary syndrome and/ or myocardial infarction); 2) CV mortality; and 3) composite outcomes (CV mortality and CAD).
Literature search
The literature search and selection process of articles included in the systematic review and meta -analysis are presented in FIGURE 1. Initially, 4 online databases were used, resulting in 8419 articles. After excluding 8341 studies, 78 full articles were assessed. Of these 78 articles, 67 had to be excluded as per the applied criteria (FIGURE 1). A final critical search based on the eligibility criteria identified only 11 articles to be included in the analysis. 29-39 Of these 11 articles, 3 were again excluded: one article did not report confidence intervals, 29 another one lacked adjustment for office BP, 31 and the third one relied on continuous parameters only. 33 Finally, 8 studies were included in the meta -analysis. 
Statistical analysis
Statistical analysis was performed using standard software package (Comprehensive Meta -Analysis v. 3 software; Biostat inc., Englewood, New Jersey, United States). A 2 -tailed P values of less than 0.05 were considered significant. The baseline characteristics of 160 mm Hg and 170 mm Hg. 8 The pathophysiology of SHRE is not fully understood, with various mechanisms proposed, including endothelial dysfunction, reduced compliance or increased stiffness of the great arteries, and high neurohormonal (mainly angiotensin II) stress-induced activation. 9 -15 Although SHRE may be clinically ignored, it has been reported to be associated with systolic and diastolic left ventricular (LV) dysfunction, 16 -22 and it can lead to target organ damage including LV hypertrophy, carotid atherosclerosis, 17-21 and significant CAD, 21 irrespective of resting BP. 22,23 However, data on its predictive value regarding those events remain contradictory. 24-27 Therefore, the aim of this review with meta -analysis was to determine the role of SHRE in predicting CV clinical outcomes in healthy normotensive individuals.
PATIENTS AND METHODS
The methodology used in this study was based on the Meta -analysis of Observational Studies in Epidemiology (MOOSE) statement for reporting systematic reviews and meta -analyses of observational studies (FIGURE 1; MOOSE checklist). 28 The literature search was undertaken independently by 2 reviewers (LP and GB) and comprised the results of the most common online databases (PubMed [MEDLINE], Cochrane Library, RefWorks, and Google Scholar), with the main focus on published studies that reported data on CV event rates and outcomes (including mortality) until July 2017 in patients with SHRE on exercise stress testing. Disagreements between reviewers were resolved by discussion with the third reviewer (MYH). The included search terms were "exercise" or "stress test"; "exercise -induced hypertension" or "hypertensive response to exercise" or "exercise -related blood pressure" or "exercise blood pressure" or "exercise exaggerated systolic blood pressure" or "exercise" and "cardiovascular event" or "cardiovascular disease" or "cerebrovascular event" or "cerebrovascular disease" or "stroke" or "mortality" or "myocardial infarction" and "outcome" or "follow -up" or "predict." The search was limited to English language, human studies, and adults (>18 years). In addition, relevant articles from reference lists were also reviewed.
WHAT'S NEW?
The clinical relevance of exaggerated systolic hypertensive response to exercise (SHRE) and its predictive value of cardiovascular events have not been fully elucidated. This meta -analysis answers those uncertainties. In a sample of 47 188 participants from 8 studies, higher SHRE was found in individuals with composite events including cardiovascular (CV) mortality and coronary artery disease, as compared with individuals with normal response. This finding highlights the importance of identifying normal individuals with exaggerated SHRE as patients with prehypertension. It also paves the way for future studies that could propose optimal means of controlling blood pressure in individuals who would otherwise be discharged from clinics based on normal office blood pressure readings, but in essence, they are at significant cardiovascular risk.
a diagnostic random effects model. 43 To obtain summary points that would consider within--study and between -study variability (heterogeneity), we performed the hierarchical summary ROC analysis using the Rutter and Gatsonis model. 44 Summary point from the hierarchical summary ROC analysis was then used to calculate positive likelihood ratio. Separate analyses were performed for different SHRE cutoffs. In studies that did not provide optimal cutoffs, we created the ROC curve and identified the optimal cutoff as the point on the ROC curve closest to 0.1 on the x -y coordinate. The OpenMetaAnalyst Yosemite software (version 12) for Windows (64 -bit version; Microsoft, Redmond, Washington, United States) was used for statistical analysis, including graphic presentations of the forest plots of sensitivity and specificity and hierarchical summary ROC curves.
RESULTS
The total number of participants from the 11 studies 33-43 included for qualitative synthesis was 53 264, with a mean follow -up of 18 years. Eight studies were eligible for the meta--analysis, 34,36,38-43 with a total of 47 188 participants and a mean follow -up of 19.3 years.
Systolic hypertensive response to exercise as a predictor of composite clinical outcomes The 8 included studies reported the following composite were reported as median and range. Mean and SD values were estimated using the method described by Hozo et al. 40 For pooled analysis, risk ratio was also considered as hazard ratio (HR). The multivariate models (including age, sex, office BP, and CV risk factors) were included in the meta -analysis. Forest plots were used to illustrate the individual results and meta -analyses. Hazard ratios with 95% CIs were presented as summary statistics for moderate and maximal exercise subgroups, and also for the overall analysis. Heterogeneity between studies was tested by the Cochran test and means of the I 2 statistic. 41 To assess the additive (between -study) component of variance, the reduced maximum likelihood method (τ 2 ) included the analysis of residual heterogeneity occurrence. 42 Studies were combined using a random effects model because of heterogeneity, in particular regarding cutoff points and outcomes. Publication bias was assessed using funnel plots and the Egger test. When 3 or more studies were included, we tested the subgroups for potential publication bias.
Diagnostic accuracy To evaluate the diagnostic accuracy of the SHRE cutoff that predicted CV events, we used a hierarchical summary receiver operating characteristic (ROC) analysis. Sensitivity and specificity with 95% CIs for individual studies were computed based on Cohort studies excluded (n = 67):
• Structural heart / great artery disease (n = 20)
• Not inclusive by design (n = 23)
• Not adequate study population (n = 12)
• Articles in other launguages (n = 4)
• Duplicate (n = 4)
• Editorial (n = 2)
• Not human study (n = 2) Cohort studies eligible for SHRE and CV event meta-analysis (n = 11)
Cohort studies included in SHRE and CV event meta-analysis (n = 8) FIGURE 2 ). There was no heterogeneity between the included studies, and outcomes: CV mortality and CAD. In all studies, patients with SHRE had a higher rate of composite events (HR, 1.363; 95% CI, 1.158-1.606; P <0.001; FIGURE 2), as compared with those with normal response. The rate of composite events did not differ between patients who achieved and those who did not achieve SHRE Systolic hypertensive response to exercise as a predictor of cardiovascular mortality Cardiovascular mortality during follow -up was reported in 5 of the 8 included studies. In all studies, the CV mortality rate was higher in patients with SHRE (HR, 1.286; 95% CI, 1.075-1.539; P = 0.006; FIGURE 4) than in those without. The CV mortality rate did not differ between patients who achieved and who did not achieve SHRE at maximal workload (P = 0.397). On the other hand, the rate was higher in patients who achieved SHRE at moderate workload (HR, 1.343; 95% CI, 1.085-1.661; P = 0.007; FIGURE 4), as compared with those who did not. There was no heterogeneity between the included studies, and there was no publication bias (P = 0.31).
Diagnostic accuracy of systolic hypertensive response to exercise for composite cardiovascular events In the ROC analysis, an SBP cutoff value of 196 mm Hg predicted composite CV events with a summary sensitivity of 62% (range, 54%-69%) and specificity of 75% (range, 60%-86%), with a positive likelihood ratio of less than 3 and a strong correlation (r = -0.71). Data are presented in FIGURE 5.
there was no publication bias either for moderate-or for maximal -exercise subgroups (P = 0.21 and P = 0.77, respectively).
Systolic hypertensive response to exercise as a predictor of coronary events Coronary artery events (acute coronary syndrome and/or myocardial infarction) during follow -up were reported in 4 of the 8 included studies. Of all the included patients, those with SHRE had a higher rate of coronary artery events during follow -up (HR, 1.532; 95% CI, 1.240-1.893; P <0.001; FIGURE 3), as compared with those with normal response. Only 1 study provided data of patients who achieved SHRE at maximal workload. The rate of coronary artery events was higher in patients who had SHRE (HR, 2.470; 95% CI, 1.460-4.179; P = 0.001), as compared with those without. The reported data from 3 other studies showed that patients who achieved SHRE at moderate workload had a higher rate of coronary artery events (HR, 1.397; 95% CI, 1.109-1.760; P = 0.005; FIGURE 3), as compared with those who had normal response. There was moderate heterogeneity between the included studies, and there was no publication bias (P = 0.8). the reported clinical outcome largely reduced this number, resulting in a potentially limited impact. We had no influence on the design of individual studies, which is a known limitation of meta--analyses. As an example, there was a higher prevalence of men in some studies, which might limit the applicability of our findings to both sexes. Despite differences in study design, our findings showed no heterogeneity or bias between the included publications. Our meta -analysis supports the importance of assessing SHRE during stress test, but it does not provide any recommendations on possible protocols. The workloads were increased with different protocols in individual studies. However, the target SHRE was achieved in all studies, and we believe that the increased SBP did not differ at the same workload between individual studies.
Conclusions
The current meta -analysis supports the clinical relevance of exaggerated SBP response to exercise as a predictor of serious composite CV clinical outcome. These findings should be considered as thought -provoking evidence for better stratification and, consequently, for optimal management of this high -risk population.
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DISCUSSION
This meta -analysis showed that SHRE, particularly at moderate exercise, was associated with a serious composite clinical outcome in the form of coronary events and CV mortality. In addition, the cutoff value of 196 mm Hg and higher for exercise SBP was strongly correlated with this clinical outcome.
Hypertension is the most dynamic CV condition. 45 While resting values could be entirely normal (according to set guidelines), they may significantly fluctuate, even up to values that could justify hospital admission in some cases. Although hypertension is difficult to predict and manage, exercise -related changes in BP are feasible and reproducible measures of this condition, hence our interest in assessing the relationship between SHRE and clinical outcome. Indeed, our analysis showed that SHRE is related to serious clinical outcomes including CV mortality and life--threatening coronary artery events in patients with satisfactory and acceptable resting or office BP values. These findings are alarming and highlight the potential adverse consequence of ignoring exercise -related hypertension. However, the question remains as to how to manage such individuals, since there are no guidelines to recommend a particular treatment, or to specify the level of SHRE at which such a treatment should be applied, or to determine the type of treatment itself. In addition, apart from the general recommendation of a healthy lifestyle for all CV patients, no particular approach is advised for these individuals to control fluctuating BP. The possibility of unmonitored cardio exercise training in these individuals raises concern, because they could exceed a systolic BP value of 200 mm Hg without proper medical attention. Based on our results, we propose a value of 196 mm Hg for systolic SHRE as a predictor of worse clinical outcome and suggest that its predictive value is confirmed in large -cohort prospective studies.
Fluctuating BP is known to have an adverse effect on arterial health, including endothelial dysfunction and arterial stiffness. If the combination of these 2 components of pressure afterload is ignored, it will affect LV diastolic function and later cavity compliance, even if systolic function is preserved. 46 In addition, in patients with persistently elevated pressure afterload, it will inevitably lead to subendocardial ischemia with the related risk of arrhythmia. 47 Finally, a perpetual increase of LV stiffness leads to left atrial enlargement along with elevated pressure, resulting in complications such as arrhythmia and thromboembolism. These consequences could explain diastolic dysfunction in middle -aged normotensive individuals with no other underlying cardiac pathology. 23 Therefore, there is an urgent need for determining physiologically acceptable BP changes associated with stress in patients with SHRE.
Limitations Although 8 studies were eligible for this analysis, subanalyses according to
